Biocryst Pharmaceuticals (BCRX) Interest Coverage Ratio (2011 - 2026)

Biocryst Pharmaceuticals has reported Interest Coverage Ratio for 16 years, with the latest figure at 35.47 in Q1 2026.

• For the quarter ending Q1 2026, Interest Coverage Ratio fell 4026.02% year-over-year to 35.47; the trailing twelve-month figure through Mar 2026 stood at 5.08 (down 1593.34% YoY), and the FY2025 full-year result was 4.32, up 16848.58% from the prior year.
• Interest Coverage Ratio for Q1 2026 stood at 35.47, down from 18.42 in the prior quarter.
• The five-year high for Interest Coverage Ratio was 18.42 in Q4 2025, with the low at 35.47 in Q1 2026.
• Historically, Interest Coverage Ratio has averaged 1.37 across 5 years, with a median of 0.59 in 2024.
• Annual changes were most pronounced in 2025 — Interest Coverage Ratio jumped 10090.73% — and 2026, when it plunged 4026.02%.
• Biocryst Pharmaceuticals' Interest Coverage Ratio stood at 1.75 in 2022, then gained by 0.83% to 1.74 in 2023, then soared by 89.38% to 0.18 in 2024, then soared by 10090.73% to 18.42 in 2025, then sank by 292.56% to 35.47 in 2026.
• The last three Interest Coverage Ratio figures came in at 35.47 (Q1 2026), 18.42 (Q4 2025), and 1.51 (Q3 2025), per Business Quant data.